Moderna Inc (NASDAQ:MRNA)
| 128.91 Delayed Data As of Jun 05 |  -1.61 / -1.23%Today’s Change | 115.03 Today|||52-Week Range 217.25 | -28.23% Year-to-Date |
Latest MRNA News | Press Releases
Today’s Trading
| Previous close | 130.51 |
| Today’s open | 131.00 |
| Day’s range | 128.84 - 134.59 |
| Volume | 3,206,071 |
| Average volume (3 months) | 3,491,189 |
| Market cap | $49.8B |
Data as of 3:59pm ET, 06/05/2023
Growth & Valuation
| Earnings growth (last year) | -29.90% |
| Earnings growth (this year) | -110.61% |
| Earnings growth (next 5 years) | -51.00% |
| Revenue growth (last year) | +3.78% |
| P/E ratio | 11.0 |
| Price/Sales | 3.91 |
| Price/Book | 2.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BIIBBiogen | +1.93 | +0.64% |
| ILMNIllumina Inc | +3.25 | +1.57% |
| ---- | ||
| BMRNBiomarin Pharmaceuti... | -1.63 | -1.75% |
Data as of 3:59pm ET, 06/05/2023
Financials
| Next reporting date | August 9, 2023 |
| EPS forecast (this quarter) | -$3.97 |
| Annual revenue (last year) | $19.1B |
| Annual profit (last year) | $8.4B |
| Net profit margin | 43.76% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
